# Angiodynamics Inc: Form 8-K, filed Mar 30, 2023

- Company: [Angiodynamics Inc](/companies/ango.md) (CIK 1275187)
- Form: 8-K
- Filed: 2023-03-30
- Accepted by EDGAR: Mar 30, 2023, 07:30 ET
- Period: 2023-03-30
- Accession: 0000914121-23-000149
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1275187/000091412123000149/an59017198-8ki.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1275187/000091412123000149/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1275187/000091412123000149/an59017198-8ki.htm

Filed Mar 30, 2023.
Source: SEC EDGAR, the filing index for accession 0000914121-23-000149. Last ingested by Listed: Nov 4, 2026, 20:24 ET. No prices; not investment advice.